![]() Physician Knowledge e-Newsletter - V 3(2) June 2006 Below you will find information related to the Knowledge Based Systems at MGHS (Please note you must be connected to the MGHS Network to gain access to these systems) Natural Medicines Comprehensive Database You can now get the
newest Natural Medicines CE course Natural Medicines in the Clinical Management
of Chronic Fatigue Syndrome.* We continue to make updates to Natural Medicines Comprehensive Database every business day. Here are a few of special interest to you. • Saw palmetto is now being questioned as an effective treatment for benign prostatic hyperplasia (BPH)...due to a surprising New England Journal of Medicine study that says saw palmetto is ineffective for moderate to severe symptoms. The study was high-quality and evaluated more patients than most previous studies. There are always questions about product quality. This study is no exception. But compared to older studies, this one appears to be more rigorous and the results seem to be valid. So why did this study have negative results and over 20 other studies were positive? Good question. No one knows for sure, but scenarios like this are common in clinical research. For now, advise patients that the evidence for saw palmetto is conflicting. Tell them that saw palmetto seems to produce modest symptom improvement for some patients. • Soy is getting a negative review from the American Heart Association. They now say that soy protein and isoflavone extracts offer little to no benefit for preventing heart disease, osteoporosis, or menopausal symptoms. It's true that there has been some conflicting evidence about the effectiveness of soy for these conditions. But most evidence suggests that soy protein can modestly decrease total and low-density lipoprotein cholesterol. Most evidence also suggests that soy protein can modestly reduce menopausal hot flashes and slow bone mineral density loss in postmenopausal women. Take the American Heart Association findings with a grain of salt. The authors failed to describe how they selected trials for inclusion in their review...and as a result, several studies seem to have been left out. Explain to patients that soy isn't a miracle food. But it might help some patients if it replaces other protein sources in their diet. • Fish oil was recently reviewed for its effect against cancer. This review was big in the news, but the findings aren't very reliable. The researchers tried to combine studies of omega-3 fatty acids from both plants and fish...and from both dietary and supplemental intake. This is a case of one study trying to do way too much. The study populations and treatments were so different in the different studies evaluated that it was impossible to pool the data for analysis. Explain to patients that there never was much evidence to support using fish oil supplements for preventing cancer. Tell patients that eating 1-2 servings of fatty fish per week is a good idea for most people...even if it doesn't reduce the risk of cancer. • Activia is a new yogurt promoted for bowel regularity. The manufacturer, Dannon, says that it "...helps naturally regulate your digestive system." It contains a probiotic that the company calls "Bifidus regularis." But this is really a strain of "Bifidobacterium animalis." There is some evidence that this strain can survive passage through the GI tract...and this could be important to any potential beneficial effect. Some evidence also suggests that eating Activia can decrease colonic transit time. This suggests that it could be beneficial for reducing constipation. But so far, there is no reliable evidence that it works for preventing constipation...or that it is any more effective than other probiotic-containing yogurts. Tell patients that there isn't enough evidence to recommend Activia over other yogurts...but Activia is probably a good choice for patients who want a yogurt with live and active cultures You can now get the newest Natural Medicines CE course Natural Medicines in the Clinical Management of Eye Disorders.* • Black cohosh
is under scrutiny due to several case reports of liver damage. In some
cases, patients have required a liver transplant. The Australian Therapeutic
Goods Administration now requires black cohosh products to carry a warning
label that indicates the risk of liver damage. Some experts say Australia's
action is an overreaction. In most reports, liver damage has been linked
to products that contain black cohosh PLUS other ingredients. These products
were not analyzed to determine if there was any contamination from adulterants.
Based on the existing reports, it is not possible to determine if black
cohosh is the actual cause of liver damage. For now, explain to patients
that there have been some reports of liver damage. If they choose to take
black cohosh, alert them to watch for symptoms of liver toxicity such
as unexplained fatigue, abdominal pain, dark urine, or jaundice. Also
encourage them to tell you or their primary physician so periodic liver
tests might be monitored. Have you noticed the
new look at naturaldatabase.com?
It's more than a cosmetic makeover. You also get a new supercharged search
feature. This means you get MORE answers...and you get them faster and
easier. STAT!Ref Scoop e-Newsletter Monthly Updates:
more >> If you would like to unsubscribe from this newsletter please send an e-mail with your name and "unsubscribe from the Physician Knowledge e-Newsletter" in the subject line to: |